HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Functional relevance of D,L-sulforaphane-mediated induction of vimentin and plasminogen activator inhibitor-1 in human prostate cancer cells.

AbstractPURPOSE:
D,L-Sulforaphane (SFN) is a promising chemopreventive agent with in vivo efficacy against prostate cancer in experimental rodents. This study was undertaken to determine the role of vimentin and plasminogen activator inhibitor-1 (PAI-1) in anticancer effects of SFN.
METHODS:
Effect of SFN on levels of different proteins was determined by Western blotting or immunofluorescence microscopy. RNA interference of vimentin and PAI-1 was achieved by transient transfection. Apoptosis was quantified by flow cytometry. Transwell chambers were used to determine cell migration.
RESULTS:
Exposure of PC-3 and DU145 human prostate cancer cells to SFN resulted in induction of vimentin protein, which was accompanied by down-regulation of E-cadherin protein expression. The SFN-mediated induction of vimentin was also observed in a normal human prostate epithelial cell line. RNA interference of vimentin did not have any appreciable effect on early or late apoptosis resulting from SFN exposure. On the other hand, SFN-mediated inhibition of PC-3 and DU145 cell migration was significantly augmented by knockdown of the vimentin protein. Knockdown of vimentin itself was inhibitory against cell migration. The SFN-treated cells also exhibited induction of PAI-1, which is an endogenous inhibitor of urokinase-type plasminogen activator system. Similar to vimentin, PAI-1 knockdown resulted in a modest augmentation of PC-3 cell migration inhibition by SFN. Tumors from SFN-treated transgenic adenocarcinoma of mouse prostate mice showed a 1.7-fold increase in vimentin protein level compared with control tumors.
CONCLUSION:
The present study indicates that vimentin and PAI-1 inductions confer modest protection against SFN-mediated inhibition of prostate cancer cell migration.
AuthorsAvani R Vyas, Shivendra V Singh
JournalEuropean journal of nutrition (Eur J Nutr) Vol. 53 Issue 3 Pg. 843-52 (Apr 2014) ISSN: 1436-6215 [Electronic] Germany
PMID24092501 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • Anticarcinogenic Agents
  • Cadherins
  • Isothiocyanates
  • Neoplasm Proteins
  • Plasminogen Activator Inhibitor 1
  • SERPINE1 protein, human
  • Sulfoxides
  • Vimentin
  • sulforaphane
Topics
  • Adenocarcinoma (drug therapy, metabolism, prevention & control)
  • Animals
  • Anticarcinogenic Agents (pharmacology, therapeutic use)
  • Apoptosis (drug effects)
  • Cadherins (antagonists & inhibitors, metabolism)
  • Cell Line
  • Cell Line, Tumor
  • Cell Movement (drug effects)
  • Down-Regulation (drug effects)
  • Gene Knockdown Techniques
  • Humans
  • Isothiocyanates (pharmacology, therapeutic use)
  • Male
  • Mice, Transgenic
  • Neoplasm Proteins (agonists, antagonists & inhibitors, genetics, metabolism)
  • Plasminogen Activator Inhibitor 1 (agonists, chemistry, genetics, metabolism)
  • Prostate (drug effects, metabolism)
  • Prostatic Neoplasms (drug therapy, metabolism, prevention & control)
  • RNA Interference
  • Sulfoxides
  • Up-Regulation (drug effects)
  • Vimentin (agonists, antagonists & inhibitors, genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: